California Physician Sentenced to 15 Years in Prison Over Forty-Five Million Dollar Billing Scheme

California Physician Sentenced to 15 Years in Prison Over Forty-Five Million Dollar Billing Scheme

2026-10-31 economy

Los Angeles, Saturday, 31 October 2026.
A California doctor received a 15-year prison term after billing public healthcare $45 million for fake cosmetic injections, even charging over $200,000 while vacationing on a Mexican beach.

The Doctor’s Deceptive Practice: A Systematic Fraud Uncovered

On October 30, 2026, a federal court in Los Angeles sentenced Dr. Violetta Mailyan, 45, of Glendale, California, to 15 years in prison for orchestrating a $45 million Medicare fraud scheme through her clinic, Healthy Way Medical Center [1][2][3]. The fraudulent operation involved billing Medicare for medically unnecessary Botox injections that were either never performed or administered on days when the clinic was closed or Mailyan was traveling internationally [1][2][3]. Prosecutors detailed how Mailyan submitted claims totaling over $19 million for injections billed on days the clinic was closed, including while she was vacationing in Cabo, Mexico, as well as in Hawaii, Las Vegas, Pennsylvania, and New York [1][2][3][6]. For example, Mailyan billed over $200,000 for purported Botox services in California while she was physically on a beach in Cabo, Mexico [1][2][3][6].

Financial Impact: Restitution and Asset Forfeiture Ordered

As part of the sentencing, the court ordered Mailyan to pay $32,904,049.41 in restitution to Medicare, reflecting the full extent of the fraudulent claims submitted [1][2][3]. Additionally, the court mandated the immediate forfeiture of over $16,029,742 in seized assets, including real estate, personal property, securities, and bank funds [1][2][3]. These penalties underscore the severe financial repercussions of healthcare fraud, which diverts critical public resources away from legitimate medical services [GPT]. The U.S. Department of Justice emphasized that the stolen funds were used to finance a lavish lifestyle, including the purchase of two Tesla vehicles (including a Cybertruck), a $12,000 17th-century crossbow, a $3,000 painting, and five California real estate properties [1][2][3][6][7].

Mailyan’s conviction and sentencing represent a significant victory for federal enforcement agencies in combating healthcare fraud. The case was investigated by the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) and the Federal Bureau of Investigation (FBI), with prosecution led by Trial Attorneys Sandor Callahan and Jeffrey A. Crapko of the U.S. Department of Justice [3]. The sentencing judge described Mailyan’s fraud as ‘truly breathtaking in scope and shocking in its duration,’ highlighting the audacity and scale of the scheme [1][2][3][6][7]. This case also aligns with broader federal efforts to crack down on healthcare fraud, including the creation of the Fraud Division in April 2026 under President Trump’s Task Force to Eliminate Fraud, chaired by Vice President J.D. Vance [3]. Since 2007, the DOJ’s Health Care Fraud Strike Force Program has charged over 6,200 defendants for billing more than $45 billion in fraudulent claims, demonstrating the persistent threat of such crimes to the integrity of public healthcare systems [3].

Economic and Public Health Fallout: The Cost of Fraudulent Billing

The economic fallout of Mailyan’s fraud extends beyond the immediate financial loss to Medicare. Fraudulent billing schemes like this one contribute to rising healthcare costs, which are ultimately borne by taxpayers and beneficiaries [GPT]. The diversion of $45 million in public funds to personal luxury expenditures represents a misallocation of resources that could have been used to provide critical healthcare services to vulnerable populations [GPT]. Furthermore, such fraudulent activities erode public trust in the healthcare system and strain the financial sustainability of programs like Medicare, which are already under significant pressure due to demographic and economic challenges [GPT]. The case also serves as a cautionary tale for corporate healthcare operators and private equity-backed medical practices, which are increasingly scrutinized for compliance with reimbursement oversight and ethical billing practices [GPT].

The legal proceedings against Mailyan culminated on October 29, 2026, when she was sentenced to 15 years in federal prison for her role in the Medicare fraud scheme [1][2][3]. Mailyan’s conviction followed a six-day jury trial in May 2026, during which she was found guilty on nine counts of wire fraud and three counts of obstruction of a criminal investigation [1][2][3]. The trial revealed that Mailyan had attempted to obstruct the investigation by falsifying medical records and forging Medicare beneficiary signatures, including for an individual incarcerated in federal prison during the alleged treatment dates [1][2][3][6][7]. The case highlights the federal government’s commitment to holding healthcare providers accountable for fraudulent billing practices, particularly those involving unnecessary or unperformed services [GPT].

Sources


Medicare fraud healthcare compliance